Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial

  • Michele Brignole
  • , Francesco Pentimalli
  • , Pietro Palmisano
  • , Maurizio Landolina
  • , Fabio Quartieri
  • , Eraldo Occhetta
  • , Leonardo Calò
  • , Giuseppe Mascia
  • , Lluis Mont
  • , Kevin Vernooy
  • , Vincent van Dijk
  • , Cor Allaart
  • , Laurent Fauchier
  • , Maurizio Gasparini
  • , Gianfranco Parati
  • , Davide Soranna
  • , Michiel Rienstra
  • , Isabelle C Van Gelder

Research output: Contribution to journalErratum / corrigendumAcademic

Abstract

In the originally published version of this manuscript, there was an error in Figure 1. The correct number of patients assigned to the Drug arm who underwent intention-to-treat analysis is 70, not 64. This error has been corrected.

Original languageEnglish
Pages (from-to)4768
Number of pages1
JournalEuropean Heart Journal
Volume42
Issue number46
DOIs
Publication statusPublished - 7 Dec 2021

Fingerprint

Dive into the research topics of 'Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial'. Together they form a unique fingerprint.

Cite this